CAB39 and colorectal cancer: Indeed, consistent with the breast cancer dataset, our analysis of the TCGA colorectal cancer dataset (Additional file 2: Figure S9b-c) indicates that EMSY as well as CAB39 are increased at the protein level in a subset of patients and associated with worse outcome.